Abyssinia Biologics
0 followers
Abyssinia is altering the world's understanding of Alzheimer's Disease from diagnostic assays with the potential for early diagnosis to treatment approaches addressing novel disease causes. Abyssinia's lead candidate ABY-71A1 is a IgG1 mAb with a high specificity for toxic soluble amyloid oligomers,... Read more
Org chart
Trebor R. Lawton
Co-Founder
Trebor R. Lawton
Collapse
Frederic Godderis
Strategy & Operations
Larry Jasinksi
Business & Device Strategy
Saira Ramasastry
Corporate Strategy
Robert Lawton
Founding Scientist
Brian Rogers
Toxicology
Eric Yuen Md
Clinical Development
Guriq Basi
Antibody Design & Optimization
Keith Jansen
Business Strategy
Mark Matejevic
Translational Science
Paul Treacy
CMC
